Altera Shipping 28-nm FPGAs - Analyst Blog
Altera Corporation ( ALTR ) recently announced that one of its early customers in the Open CL for FPGAs program - goHDR has achieved successful results with the same.
Altera Corporation manufactures a wide array of products such as programmable logic devices (PLDs) which consist of field-programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs). These are standard semiconductor integrated circuits or chips which customers program to execute required logic functions in their electronic systems.
The company achieved a significant reduction in development time and a dramatic increase in performance leveraging Altera's OpenCL for FPGAs.
In tandem with Altera, goHDR ported its proprietary C-code to the OpenCL standard and implemented the code in an FPGA in less than a week. Generally, this process requires 3-6 months using a traditional HDL flow.
Meanwhile, last month, Altera announced that it started shipping its 28-nm Cyclone V FPGAs.
The FPGA family consist of Stratix, Cyclone, Arria, APEX, FLEX and ACEX series. Altera has designed its Cyclone product families using advanced CMOS process technology and enable programmable flexibility to cost-sensitive applications in all its markets.
The Cyclone IV and Cyclone V FPGAs use low-power process technology to meet market requirements for low power consumption. The shipment of the Cyclone V family from Altera completes Altera's release of its 28-nm tailored product portfolio. These products meet a wide range of customer requirements from the highest bandwidth to the lowest power.
Altera, which competes with Xilinx, Inc ( XLNX ) introduced its 28nm FPGAs in 2011. Backed with the success of 40nm products, the company continues to gain momentum in its 28nm products.
We continue to maintain an Underperform recommendation on Altera. Our recommendation is supported by Zacks #4 Rank, which translates into a short-term rating of Sell.
ALTERA CORP ( ALTR ): Free Stock Analysis Report
XILINX INC ( XLNX ): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research